Ceftriaxone in infants less than 1 month has which notable side effect?

Enhance your Step 2 prep with AMBOSS 200 HY Concepts. Dive into flashcards and MCQs, each with detailed explanations. Ace your exam with confidence!

Multiple Choice

Ceftriaxone in infants less than 1 month has which notable side effect?

Explanation:
In very young infants, ceftriaxone has unique safety concerns tied to bilirubin metabolism and biliary excretion. It can displace bilirubin from albumin, increasing free bilirubin levels. In neonates, whose blood-brain barrier and bilirubin-handling systems are immature, this rise in free bilirubin can cross into the brain and cause kernicterus, a serious neurologic complication. At the same time, ceftriaxone is excreted into the bile, and in neonates the biliary system is immature, so the drug can form precipitates with calcium, leading to biliary sludge or even pseudolithiasis. These Neonate-specific risks explain why kernicterus and biliary sludge are notable adverse effects in this age group.

In very young infants, ceftriaxone has unique safety concerns tied to bilirubin metabolism and biliary excretion. It can displace bilirubin from albumin, increasing free bilirubin levels. In neonates, whose blood-brain barrier and bilirubin-handling systems are immature, this rise in free bilirubin can cross into the brain and cause kernicterus, a serious neurologic complication. At the same time, ceftriaxone is excreted into the bile, and in neonates the biliary system is immature, so the drug can form precipitates with calcium, leading to biliary sludge or even pseudolithiasis. These Neonate-specific risks explain why kernicterus and biliary sludge are notable adverse effects in this age group.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy